izpis_h1_title_alt

Pharmacokinetics of carprofen in anaesthetized pigs : a preliminary study
ID Omerzel, Maša (Avtor), ID Kržan, Mojca (Avtor), ID Lampreht Tratar, Urša (Avtor), ID Dolenc, Jožica (Avtor), ID Čemažar, Maja (Avtor), ID Seliškar, Alenka (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (802,80 KB)
MD5: 7A1141BA1C8DD03614599DFC1FB1F87B
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S1467298720302270?via%3Dihub Povezava se odpre v novem oknu
Opis: članek dostopen za konzorcij UL

Izvleček
Objective To investigate the pharmacokinetics of carprofen after a single intravenous (IV) dose and multiple oral doses administered to pigs undergoing electroporation of the pancreas. Study design Prospective experimental study. Animals A group of eight female pigs weighing 31.74 ± 2.24 kg (mean ± standard deviation). Methods Carprofen 4 mg kg−1 was administered IV after placement of a central venous catheter during general anaesthesia with isoflurane. Blood samples were collected 30 seconds before and 5, 10, 20, 30 and 60 minutes and 2, 4, 6, 8, 12 and 24 hours after carprofen administration. Subsequently, the same dose of carprofen was administered orally, daily, for 6 consecutive days and blood collected at 36, 48, 60, 72, 96, 120, 144 and 168 hours after initial carprofen administration. Plasma was analysed using liquid chromatography with mass spectrometry. Standard pharmacokinetic parameters were calculated by compartmental analysis of plasma concentration–time curves. Data are presented as mean ± standard error. Results The initial plasma concentration of IV carprofen was estimated at 54.57 ± 3.92 μg mL−1 and decreased to 8.26 ± 1.07 μg mL−1 24 hours later. The plasma elimination curve showed a bi-exponential decline: a rapid distribution phase with a distribution half-life of 0.21 ± 0.03 hours and a slower elimination phase with an elimination half-life of 17.31 ± 3.78 hours. The calculated pharmacokinetic parameters were as follows: the area under the plasma concentration–time curve was 357.3 ± 16.73 μg mL−1 hour, volume of distribution was 0.28 ± 0.07 L kg−1 and plasma clearance rate was 0.19 ± 0.009 mL minute−1 kg−1. The plasma concentration of carprofen, administered orally from days 2 to 7, varied from 9.03 ± 1.87 to 11.49 ± 2.15 μg mL−1. Conclusions and clinical relevance Carprofen can be regarded as a long-acting non-steroidal anti-inflammatory drug in pigs.

Jezik:Angleški jezik
Ključne besede:Carprofen, pharmacokinetics, swine
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
VF - Veterinarska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Recenzirani rokopis
Datum objave:19.01.2021
Leto izida:2021
Št. strani:Str. 35-41
Številčenje:Vol. 48, no. 1
PID:20.500.12556/RUL-124473 Povezava se odpre v novem oknu
UDK:636.4.09:616-089
ISSN pri članku:1467-2987
DOI:10.1016/j.vaa.2020.09.006 Povezava se odpre v novem oknu
COBISS.SI-ID:34537987 Povezava se odpre v novem oknu
Datum objave v RUL:25.01.2021
Število ogledov:902
Število prenosov:328
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Veterinary anaesthesia and analgesia
Skrajšan naslov:Vet. anaesth. analg.
Založnik:Elsevier
ISSN:1467-2987
COBISS.SI-ID:1098874 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:25.01.2021

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0053
Naslov:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0092
Naslov:Zdravje živali, okolje in varna hrana

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0003
Naslov:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0067
Naslov:Farmakologija in farmakogenomika

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj